Abstract:Most ambulatory young adults with acute influenza have clinically insignificant abnormal electrocardiogram findings early during the illness. These abnormalities resolve promptly and are not associated with changes in cardiac markers or echocardiogram findings.
“…Fever and cough were the most frequent symptoms in ILI patients. Fever was reported more often by H1N1 positive patients (91% vs. 72.9%; P < 0.01), with similar numbers found in literature, 87.3-95.9% [13,14,18,19]. Incidence of headache was also higher in H1N1 positive group (31.8% vs. 18.5%; P < 0.05).…”
Section: Discussionsupporting
confidence: 81%
“…History of drug allergies or asthma was more common in H1N1 positive patients; the same is reported by other researchers [4,19]. Other chronic pulmonary diseases (e.g.…”
In this study patients infected with Influenza A H1N1 differed from H1N1 negative ILI patients in several clinical and laboratory characteristics. The same was observed also by other investigators. The results of the study suggest some other specific features, such as a higher incidence of headache and higher values of troponin in Influenza A H1N1 infected patients.
“…Fever and cough were the most frequent symptoms in ILI patients. Fever was reported more often by H1N1 positive patients (91% vs. 72.9%; P < 0.01), with similar numbers found in literature, 87.3-95.9% [13,14,18,19]. Incidence of headache was also higher in H1N1 positive group (31.8% vs. 18.5%; P < 0.05).…”
Section: Discussionsupporting
confidence: 81%
“…History of drug allergies or asthma was more common in H1N1 positive patients; the same is reported by other researchers [4,19]. Other chronic pulmonary diseases (e.g.…”
In this study patients infected with Influenza A H1N1 differed from H1N1 negative ILI patients in several clinical and laboratory characteristics. The same was observed also by other investigators. The results of the study suggest some other specific features, such as a higher incidence of headache and higher values of troponin in Influenza A H1N1 infected patients.
“…Clinical findings in patients with influenza were consistent with typical systemic effects, such as high temperature, muscle pain and fatigue, and also indicated frequent episodes of myocardial ischemia (Greaves et al, 2003;Ison et al, 2005;Paul, 1963;Verel et al, 1976). These results led to the hypothesis that influenza may play a role in triggering cardiovascular events.…”
Abstract:The obtained results have confirmed the efficacy of Nuclex in terms of normalisation of parameters of coronary reserve, and in terms of elimination of the main signs and symptoms of influenza and acute upper respiratory tract infection (URTI), in particular, normalisation of body temperature, disappearance of headache, catarrhal phenomena, and general fatigue. The decrease in intensity of these signs and symptoms in the study group appeared one to three days earlier than in the control group, and this difference remained significant until the end of treatment. On the 14th day of Nuclex intake influenza A virus H1N1 could not be found by means of PCR in 58.33% of the study group patients, meanwhile in the control group patients the virus was still detectable. The results have clearly demonstrated the significant difference in the treatment efficacy between the control and study groups thus favouring the latter. Nuclex has been proven effective to completely remove the influenza virus from the body.
“…Typically, clinical manifestations are mild and result in uncomplicated cases, but there have been reports of fatal cases from cardiac involvement (8). ECG abnormalities can be seen in up to 45% of individual infected with influenza, including ST deviation, T wave flattening, Q wave formation, and atrial fibrillation (9). Observational studies have suggested that influenza viruses can trigger cardiovascular death and that vaccines against influenza may decrease the risk of cardiovascular events in susceptible individuals (10).…”
Introduction: The cardiac manifestations of influenza A are broad, ranging from self-limited pericarditis to fatal cardiomyopathy. The 2009 H1N1 influenza A (H1N1) strain is a rare cause of pericarditis, and its role in developing a pericardial effusion leading to tamponade has infrequently been reported. Case Presentation: We describe a case of a young female with no prior cardiovascular history who presents with a pericardial effusion and shock secondary to cardiac tamponade from pericarditis due to H1N1 influenza A. Conclusions: This case highlights the potential severity of H1N1 infections and the utility of considering cardiac tamponade in patients presenting with influenza symptoms and circulatory collapse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.